Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2018-04-19
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine Premedication for Post-anaesthesia Sleep Disturbance
NCT06281561
Safety Study of Dexmedetomidine in Elderly Under General Anesthesia
NCT05567523
Dexmedetomidine Versus Propofol for Sedation During Awake Endotracheal Intubation
NCT04753515
EEG DSA-guided Intravenous Anesthesia Using Dexmedetomidine and Propofol
NCT05656547
Effect of Sedatives on Regional Cerebral Oxygen Saturation
NCT02966743
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each group will have 20 patients.
General conditions including blood pressure, respiration, and heart rates will be recorded.
EEG power spectra activity will be recorded no-invasively by a Narcotrend EEG monitor.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients will receive intravenous propofol infusion.
No interventions assigned to this group
Dexmedetomidine 0.5 microgram/kg group
Patients will receive dexmedetomidine 0.5 microgram/kg and then intravenous propofol infusion.
No interventions assigned to this group
Dexmedetomidine 1 microgram/kg group
Patients will receive dexmedetomidine 1 microgram/kg and then intravenous propofol infusion.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body mass index 18 to 25 kg/m2
* no vision or hearing impairment
* will receive general anesthesia
Exclusion Criteria
* with neurological diseases
* treating with steroids or with alcohol dependence.
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Zhiyi Zuo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhiyi Zuo
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sun Yat-Sen Memorial Hospital
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.